Isosterism and bioisosterism in drug design.
暂无分享,去创建一个
[1] G. R. Brown,et al. Receptor binding sites of hypoglycemic sulfonylureas and related [(acylamino)alkyl]benzoic acids. , 1984, Journal of medicinal chemistry.
[2] H. Schaeffer,et al. Novel substrate of adenosine deaminase. , 1971, Journal of medicinal chemistry.
[3] C. Hansch,et al. On the structure of medicinal chemistry. , 1976, Journal of medicinal chemistry.
[4] A. Leo,et al. Substituent constants for correlation analysis. , 1977, Journal of medicinal chemistry.
[5] E. Gravela,et al. In the search for new anticancer drugs. 13. Phosphonic and phosphinic analogues of ornithine. , 1985, Journal of medicinal chemistry.
[6] D. J. Bauer,et al. 9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group , 1978, Nature.
[7] R. S. Mulliken. Bonding Power of Electrons and Theory of Valence. , 1931 .
[8] W. B. Wright,et al. Thromboxane synthetase inhibitors and antihypertensive agents. 1. N-[(1H-imidazol-1-yl)alkyl]aryl amides and N-[(1H-1,2,4-triazol-1-yl)alkyl]aryl amides. , 1986, Journal of medicinal chemistry.
[9] Y. Kondo,et al. Antimalarial phenanthrene amino alcohols.1. Fluorine-containing 3- and 6-substituted 9-phenanthrenemethanols. , 1971, Journal of medicinal chemistry.
[10] M. Hropot,et al. 5-sulfamoylorthanilic acids, a sulfonamide series with salidiuretic activity. , 1983, Journal of medicinal chemistry.
[11] L. Small,et al. Amino Alcohols Derived from Carbazole. II1 , 1938 .
[12] A. Burger,et al. D-Glucopyranose 6-Deoxy-6-phosphonic Acid , 1956 .
[13] H. Brown,et al. The Structure and Toxicity of DDT Insecticides , 1953 .
[14] G. Cooper,et al. META-AMINO PARA-HYDROXY PHENYL ARSINE OXIDE AS AN ANTISYPHILITIC AGENT. , 1932, Science.
[15] C. Hansch,et al. A NEW SUBSTITUENT CONSTANT, PI, DERIVED FROM PARTITION COEFFICIENTS , 1964 .
[16] R. R. Bower,et al. Synthesis and anti-herpes simplex activity of analogues of phosphonoacetic acid. , 1977, Journal of medicinal chemistry.
[17] D. Miller,et al. Dopaminergic agonists: comparative actions of amine and sulfonium analogues of dopamine. , 1984, Journal of medicinal chemistry.
[18] C. Hansch,et al. p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure , 1964 .
[19] Orville H. Miller,et al. The Synthesis of Several Dialkylmalonylguanidines with a Preliminary note on their Pharmacology , 1941 .
[20] L. Overby,et al. ANTIVIRAL POTENTIAL OF PHOSPHONOACETIC ACID , 1977, Annals of the New York Academy of Sciences.
[21] A. Leo,et al. Substituent constants for correlation analysis in chemistry and biology , 1979 .
[22] K. Florey,et al. Analytical profiles of drug substances , 1972 .
[23] A. Burger,et al. Antimalarials. II. Alpha-(2-piperidyl)-and alpha-(2-pyridyl)-2-trifluoromethyl-4-quinolinemethanols. , 1968, Journal of medicinal chemistry.
[24] A. C. Brown,et al. V.—On the Connection between Chemical Constitution and Physiological Action. Part. I.—On the Physiological Action of the Salts of the Ammonium Bases, derived from Strychnia, Brucia, Thebaia, Codeia, Morphia, and Nicotia , 1870, Transactions of the Royal Society of Edinburgh.
[25] W. Carter. Selective Inhibitors Of Viral Functions , 1973 .
[26] R. Kuhn,et al. 4.4′-Diamino-benzophenon und andere schwefelfreie Verbindungen mit Sulfonamidwirkung , 1942 .
[27] J. C. Emmett,et al. Thyroid hormone analogues. Synthesis of 3'-substituted 3,5-diiodo-L-thyronines and quantitative structure-activity studies of in vitro and in vivo thyromimetic activities in rat liver and heart. , 1988, Journal of medicinal chemistry.
[28] J. Büchi,et al. Synthese und analgetische Wirkung einiger 1‐Methyl‐4‐phenyl‐piperidin‐(4)‐alkylsulfone. 1. Mitteilung , 1952 .
[29] W J Dunn,et al. Linear relationships between lipophilic character and biological activity of drugs. , 1972, Journal of pharmaceutical sciences.
[30] J. Bruin,et al. Synthesis of 8-azaprostaglandin E1 and E2 , 1976 .
[31] H. Schaeffer,et al. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[32] H. Erlenmeyer,et al. Über Pseudoatome und isostere Verbindungen. Ein Vergleich der Gruppen N2 und CO , 1933 .
[33] Y. Martin,et al. Quantitative drug design: A critical introduction , 1978 .
[34] R. K. Robins,et al. Broad-Spectrum Antiviral Activity of Virazole: 1-f8- D-Ribofuranosyl- 1,2,4-triazole- 3-carboxamide , 1972, Science.
[35] W. J. Novick,et al. [(3-aryl-1,2-benzisoxazol-6-yl)oxy]acetic acids. A new diuretic series. , 1982, Journal of medicinal chemistry.
[36] J. Kraus,et al. Isosterism and molecular modification in drug design: tetrazole analogue of GABA: effects on enzymes of the gamma-aminobutyrate system. , 1983, Pharmacological research communications.
[37] G. Blackburn,et al. Isopolar vs Isosteric Phosphonate Analogues of Nucleotides , 1985 .
[38] R. Shepherd,et al. Sulfanilamidopyrimidines. I. 4-Sulfanilamidopyrimidines by Heterocyclic Nucleophilic Displacements , 1961 .
[39] F. Hauser,et al. 10-oxa-11-desoxy-prostaglandins , 1974 .
[40] J. Druey,et al. Heilmittelchemische Untersuchungen in der heterocyclischen Reihe. Mitteilung. Pyrazolo‐(3,4‐d)‐pyrimidine , 1956 .
[41] E. Hessler. An efficient synthesis of 1-beta-D-arabinofuranosylcytosine. , 1976, The Journal of organic chemistry.
[42] H. Köhler,et al. Dicyanmethanido‐ und Cyanamido‐oxoanionen. Untersuchungen zum sauerstoffanalogen Charakter der C(CN)2‐ und NCN‐Gruppen , 1970 .
[43] R. Schinazi,et al. Synthesis and antiviral activity of various 3'-azido analogues of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1, HTLV-III/LAV). , 1988, Journal of medicinal chemistry.
[44] R. C. Elderfield,et al. STUDIES IN THE PYRIDINE SERIES. II. SYNTHESIS OF 2-METHYL-3-(β-HYDROXYETHYL)PYRIDINE AND OF THE PYRIDINE ANALOG OF THIAMINE (VITAMIN B1) , 1941 .
[45] J. T. Litchfield,et al. The sulfonamides and allied compounds , 1948 .
[46] M. Wolff,et al. Antibody-directed drug discovery , 1990, Nature.
[47] P. Goldman,et al. Nitrosoimidazoles: highly bactericidal analogues of 5-nitroimidazole drugs. , 1988, Journal of medicinal chemistry.
[48] C. Ho,et al. Synthesis and in vitro antimicrobial activity of 5-substituted 2H-1,3,5-thiadiazine-2,4(3H)-diones. , 1982, Journal of medicinal chemistry.
[49] H. Erlenmeyer,et al. Zur Kenntnis der Eigenschaften isosterer und strukturähnlicher Verbindungen VII. Über die Darstellung des 4‐Oxy‐benzthiazol , 1938 .
[50] G. Spiteller,et al. Zweitsynthese des 6-Sulfanilamido-2,4-dimethoxy-pyrimidins und Synthese des 6-Sulfanilamido-2-methoxy-4,5-dimethylpyrimidins 6. Mitt. über neue N 1 -substituierte Sulfonamide , 1961 .
[51] C. Nathan,et al. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs 1 , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[52] H. Erlenmeyer,et al. Beiträge zum Problem der Ähnlichkeit bei Komplexverbindungen. Metallionen und biologische Wirkung, 19. Mitteilung , 1954 .
[53] J. Burckhalter. Molecular Modification in Drug Design , 1966 .
[54] J. Lockhart,et al. 784. The denitration of nitroguanidines in strong acids. Part II. Absorption spectra and pKa values of certain nitroguanidines , 1958 .
[55] D. L. Tabern,et al. Sulfur-Containing Barbiturate Hypnotics , 1935 .
[56] K. Wallenfels,et al. The Analogy between O and C(CN)2 , 1976 .
[57] R. R. Burtner,et al. Antispasmodics. I. Basic Esters of Some Arylacetic Acids1 , 1943 .
[58] R. Curley,et al. Synthesis of aminomethyl-substituted cyclic imide derivatives for evaluation as anticonvulsants. , 1983, Journal of medicinal chemistry.
[59] D. Ward,et al. Nucleoside analogs with antiviral activity. , 1976, Biochemical pharmacology.
[60] R. Robinson,et al. 355. β-Phenylfurylethylamine and analogous derivatives of thiophen and pyrrole , 1939 .
[61] N. B. Eddy,et al. Theories of general anesthesia. , 1950 .
[62] R. Sidwell,et al. Synthesis and antiviral and antimicrobial activity of certain 1-beta-D-ribofuranosyl-4,5-disubstituted imidazoles. , 1976, Journal of medicinal chemistry.
[63] C. Harris,et al. The synthesis and biological activities of some 12-Aza-prostaglandin analogues , 1978 .
[64] D. Cram,et al. The design of molecular hosts, guests, and their complexes , 1988, Science.
[65] E. Cragoe,et al. Prostaglandin isosteres. 1. (8-Aza-, 8,10-diaza-, and 8-aza-11-thia)-9-oxoprostanoic acids and their derivatives. , 1977, Journal of medicinal chemistry.
[66] H. Lewis,et al. NUCLEOSIDES. I. A NEW SYNTHESIS OF 1-BETA-D-ARABINOFURANOSYL PYRIMIDINE NUCLEOSIDES. , 1965, The Journal of organic chemistry.
[67] L. D. Freedman,et al. The Preparation And Properties Of Phosphonic Acids , 1957 .
[68] A. L. Morrison,et al. 303. Synthetic analgesics. Part VI. The synthesis of ketobemidone , 1950 .
[69] R. I. Thrift. Derivatives of 2-aminoetetralin , 1967 .
[70] T. Eggelte,et al. Synthesis of 9,11-dideoxy-9a-homoprostaglandins† , 1977 .
[71] L. Overby,et al. Inhibition of DNA Polymerase from Herpes Simplex Virus-Infected Wi-38 Cells by Phosphonoacetic Acid , 1975, Journal of virology.
[72] E. Mack,et al. THE ANGLE BETWEEN THE OXYGEN BONDS BY THE COLLISION AREA METHOD , 1932 .
[73] P. Polster,et al. The effect of cardiac muscle of two drugs related to amiodarone, L8040 and L8462. , 1974, European journal of pharmacology.
[74] Beziehungen zwischen der Struktur der Antigene und der Spezifität der Antikörper , 1933 .
[75] D. K. Phillips,et al. Bulky amine analogues of ketoprofen: potent antiinflammatory agents. , 1984, Journal of medicinal chemistry.
[76] F. Westheimer. Why nature chose phosphates. , 1987, Science.
[77] C. Le. Curariform activity and chemical structure. , 1948 .
[78] W. Steinkopf,et al. XVIII. Die Synthese des Thiophen‐isologen des Atropins , 1924 .
[79] D. B. Ellis,et al. Synthesis and neuroleptic activity of 3-(1-substituted-4-piperidinyl)-1,2-benzisoxazoles. , 1985, Journal of medicinal chemistry.
[80] D. Green,et al. On the dopamine‐like action of apomorphine , 1971, The Journal of pharmacy and pharmacology.
[81] P. Kovacic,et al. Spirobarbituric Acids Containing a Six-membered Carbocyclic Ring , 1949 .
[82] J. Clemens,et al. Bicyclic and tricyclic ergoline partial structures. Rigid 3-(2-aminoethyl)pyrroles and 3- and 4-(2-aminoethyl)pyrazoles as dopamine agonists. , 1980, Journal of medicinal chemistry.
[83] J. M. Weaver,et al. Mesoionic pyridazine ribonucleosides. A novel biologically active nucleoside metabolite. , 1984, Journal of medicinal chemistry.
[84] R. Roblin,et al. Studies in Chemotherapy. VIII. Methionine and Purine Antagonists and their Relation to the Sulfonamides1 , 1945 .
[85] R. G. Schmitt,et al. Spectrophotometrically Determined Ionization Constants of Derivatives of Symmetric Triazine. , 1961 .
[86] B. Branchaud,et al. Synthesis of 11-deoxy-8-azaprostaglandin E1. , 1977, The Journal of organic chemistry.
[87] R. Foster,et al. Studies in analgesia; piperidine derivatives with morphine-like activity. , 1947, The Journal of pharmacology and experimental therapeutics.
[88] E. Gravela,et al. IN SEARCH OF NEW ANTICANCER DRUGS. 13. PHOSPHONIC AND PHOSPHINIC ANALOGS OF ORNITHINE , 1985 .
[89] Aalt Bast,et al. Comprehensive medicinal chemistry , 1991 .
[90] G. Hitchings,et al. THE EFFECTS OF PYRIMIDINES ON THE GROWTH OF LACTOBACILLUS CASEI. , 1945, Science.
[91] H. Blank,et al. Inhibition of Growth of Hair by Mimosine , 1962, Nature.
[92] S H Unger,et al. "Aromatic" substituent constants for structure-activity correlations. , 1973, Journal of medicinal chemistry.
[93] M. Soodak,et al. Studies on Oxythiamine , 1944 .
[94] C. Heidelberger,et al. THE SYNTHESIS OF 5-FLUOROPYRIMIDINES , 1957 .
[95] A. Korolkovas. Drug Action. (Book Reviews: Essentials of Molecular Pharmacology. Background for Drug Design) , 1970 .
[96] J. Mao,et al. Mode of inhibition of herpes simplex virus DNA polymerase by phosphonoacetate. , 1975, Biochemistry.
[97] D. Woolley,et al. SELECTIVE REVERSIBLE INHIBITION OF MICROBIAL GROWTH WITH PYRITHIAMINE , 1943, The Journal of experimental medicine.
[98] P. Anderson,et al. N-(1,3,4,6,7,12b-hexahydro-2H-benzo[b]furo[2,3-a]quinolizin -2-yl)-N- methyl-2-hydroxyethane-sulfonamide: a potent and selective alpha 2-adrenoceptor antagonist. , 1985, Journal of medicinal chemistry.
[99] H. Erlenmeyer,et al. Zusammenhänge zwischen Konstitution und Wirkung bei Pyrazolonderivaten , 1935 .
[100] S. Archer,et al. The preparation and properties of some benzohydryl sulfones. , 1948, Journal of the American Chemical Society.
[101] Molecular complexes of thyroid hormone tyrosyl rings with aromatic donors. Possible relationship to receptor protein interactions. , 1988, Journal of medicinal chemistry.
[102] J. Rokach,et al. Kojic amine--a novel gamma-aminobutyric acid analogue. , 1979, Journal of medicinal chemistry.
[103] I. M. Klotz,et al. The antibacterial activity of p-aminobenzenephosphonous acid. , 1947, Journal of the American Chemical Society.
[104] D. Ledbetter,et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. , 1989, Science.
[105] G. Barger,et al. 399. Synthesis of β-2-thienylalanine and of β-2-thienylethylamine , 1938 .
[106] Carl-Eric Kaiser,et al. Dopamine receptors: Functions, subtypes and emerging concepts , 1985, Medicinal research reviews.
[107] F. Bossert,et al. [Dihydropyridines, a new group of strongly effective coronary therapeutic agents]. , 1971, Die Naturwissenschaften.
[108] D. Walters,et al. Potential antisecretory antidiarrheals. 1. Alpha 2-adrenergic aromatic aminoguanidine hydrazones. , 1988, Journal of medicinal chemistry.
[109] A. Burger,et al. A Guide to the Chemical Basis of Drug Design , 1983 .
[110] G. B. Brown,et al. THE INHIBITION OF THE GROWTH OF YEAST BY THIENYLALANINE , 1945 .
[111] W. Steinkopf,et al. Studien in der Thiophenreihe XVII. Die Darstellung des Thiophenisologen des Cocains , 1924 .
[112] G. M. Drew,et al. Peripheral dopamine receptor subtypes- a closer look , 1985 .
[113] J. Monn,et al. Conformational preference for the binding of biaryl substrates and inhibitors to the active site of phenylethanolamine N-methyltransferase. , 1988, Journal of medicinal chemistry.
[114] T. C. Bruice,et al. A correlation of thyroxine-like activity and chemical structure. , 1956, Archives of biochemistry and biophysics.
[115] B. Belleau,et al. Synthesis and crystal structure of 17-deaza-17-methyl thionium isomorphinan (isosulforphanol) perchlorate, an isostere of the opiate isolevorphanol , 1985 .
[116] A. Burger,et al. 3-Iodo-, 3,3'-Diiodo- and 3,3'-Diiodo-5-bromothyronine1 , 1956 .
[117] A. Patchett,et al. Inhibitors of glycolic acid oxidase. 4-substituted 2,4-dioxobutanoic acid derivatives. , 1983, Journal of medicinal chemistry.
[118] E. Huang. Human cytomegalovirus. IV. Specific inhibition of virus-induced DNA polymerase activity and viral DNA replication by phosphonoacetic acid , 1975, Journal of virology.
[119] H. Gilman,et al. THE CORRELATION OF SOME AROMATIC TYPES WITH PHYSIOLOGICAL ACTION. LOCAL ANESTHETICS CONTAINING THE FURAN, THIOPHENE AND PYRROLE NUCLEI1 , 1925 .
[120] Y. Martin,et al. A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry. , 1981, Journal of medicinal chemistry.
[121] V. Goldschmidt. Krystallbau und chemische Zusammensetzung , 1927 .
[122] D. Calne,et al. (+)-4-PROPYL-9-HYDROXYNAPHTHOXAZINE (PHNO), A NEW DOPAMINOMIMETIC, IN TREATMENT OF PARKINSONISM , 1985, The Lancet.
[123] C. Broquet,et al. Structure-activity relationship in PAF-acether. 4. Synthesis and biological activities of carboxylate isosteres. , 1988, Journal of medicinal chemistry.
[124] R. A. Johnson,et al. Thromboxane A2 synthase inhibitors. 5-(3-Pyridylmethyl)benzofuran-2-carboxylic acids. , 1986, Journal of medicinal chemistry.
[125] D. Woolley,et al. PRODUCTION OF THIAMINE DEFICIENCY DISEASE BY THE FEEDING OF A PYRIDINE ANALOGUE OF THIAMINE , 1943 .
[126] I. Page,et al. Nature of the hypotensive action of a thiophanium derivative (Ro 2-2222) in dogs. , 1952, The Journal of pharmacology and experimental therapeutics.
[127] A. R. Patel,et al. Antimalarials. 7. Bis(trifluoromethyl)-.alpha.-(2-piperidyl)-4-quinolinemethanols , 1971 .
[128] S. Free,et al. A MATHEMATICAL CONTRIBUTION TO STRUCTURE-ACTIVITY STUDIES. , 1964, Journal of medicinal chemistry.
[129] T. Fujita,et al. Structure-activity study of phenethylamines as substrates of biosynthetic enzymes of sympathetic transmitters. , 1971, Journal of medicinal chemistry.
[130] M. Goodman. Peptide homologs, isosteres, and isomers: A general approach to structure–activity relationships , 1985, Biopolymers.
[131] C. Hansch,et al. The use of triazine inhibitors in mapping the active site region of Lactobacillus casei dihydrofolate reductase. , 1979, Archives of biochemistry and biophysics.
[132] W. Hieber,et al. Über Metallcarbonyle. VII. Über die Raumbeanspruchung des Kohlenoxyds in seinen Metallsalz‐Verbindungen und in den Metallcarbonylen , 1930 .
[133] C. Thornber,et al. Isosterism and molecular modification in drug design , 1979 .
[134] J. Katzenellenbogen,et al. Acylamino boronic acids and difluoroborane analogues of amino acids: potent inhibitors of chymotrypsin and elastase. , 1985, Journal of medicinal chemistry.
[135] C. Suter. Relationships between the Structure and the Bactericidal Properties of Phenols. , 1941 .
[136] E. De Clercq,et al. (S)-9-(2,3-Dihydroxypropyl)adenine: An Aliphatic Nucleoside Analog with Broad-Spectrum Antiviral Activity , 1978, Science.
[137] I. Langmuir. ISOMORPHISM, ISOSTERISM AND COVALENCE. , 1919 .
[138] J. B. Farmer,et al. α-[(t-Butylamino)methyl]-4-hydroxy-m-xylene-α1, α3-diol (AH.3365): a Selective β-Adrenergic Stimulant , 1968, Nature.
[139] M. Wolff,et al. Apparent bioisosteric replacement of--S--by NCN: synthesis of N--cyano-2-aza-A-nor-5alpha-androstan-17beta-ol acetate, an aza steroid androgen. , 1979, Journal of medicinal chemistry.
[140] J. L. Barker,et al. Salicylate: A Structure-Activity Study of its Effects on Membrane Permeability , 1972, Science.
[141] L. Birckenbach,et al. Über die Cyan-Abkömmlinge der flüchtigen Hydride , 1930 .
[142] G. Hitchings,et al. Metabolic studies of allopurinol, an inhibitor of xanthine oxidase. , 1966, Biochemical pharmacology.
[143] L. Birckenbach,et al. Über Pseudohalogene (I) , 1925 .
[144] J. Jones,et al. 11,12-secoprostaglandins. 4. 7-(N-alkylmethanesulfonamido) heptanoic acids. , 1977, Journal of medicinal chemistry.
[145] A. Leo,et al. Partition coefficients and their uses , 1971 .
[146] R. K. Robins. Potential Purine Antagonists. I. Synthesis of Some 4,6-Substituted Pyrazolo [3,4-d] pyrimidines1 , 1956 .
[147] C. Triggle,et al. Chemical pharmacology of the synapse , 1976 .
[148] K. Miescher,et al. Über eine neue Synthese morphinähnlich wirkender 4-Phenylpiperidin-4-alkylketone und verwandter Verbindungen , 1949 .
[149] D W Barry,et al. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[150] H. van de Waterbeemd,et al. Theoretical conformational studies on some dopamine antagonistic benzamide drugs: 3-pyrrolidyl- and 4-piperidyl derivatives. , 1983, Journal of medicinal chemistry.
[151] J. Black,et al. Potential histamine H2-receptor antagonists. 2. N-alpha-Guanylhistamine. , 1975, Journal of medicinal chemistry.
[152] L. Birckenbach,et al. Über Pseudohalogene, IV.: Die Hydrolysen-Konstanten des Brom-tricyanmethyls und des Chlor-, Brom- und Jod-trinitromethyls , 1929 .
[153] G. W. Wheland,et al. Resonance in Organic Chemistry , 1956 .
[154] G. Diana,et al. Synthesis of some phosphonates with antiherpetic activity. , 1984, Journal of medicinal chemistry.